Research output per year
Research output per year
Personal profile
Fields of Science
- 317 Pharmacy
- neuropharmacology
- neurotrophic factors
- drug craving
- Parkinson's disease
- ischemic brain injury
- gene therapy
- 3112 Neurosciences
International and National Collaboration
Publications and projects within past five years.
-
ARG1-expressing microglia show a distinct molecular signature and modulate postnatal development and function of the mouse brain
Stratoulias, V., Ruiz, R., Kanatani, S., Osman, A. M., Keane, L., Armengol, J. A., Rodriguez-Moreno, A., Murgoci, A-N., Garcia-Dominguez, I., Alonso-Bellido, I., Ibanez, F. G., Picard, K., Vazquez-Cabrera, G., Posada-Perez, M., Vernoux, N., Tejera, D., Grabert, K., Cheray, M., Gonzalez-Rodriguez, P., Perez-Villegas, E. M., & 12 others, 11 May 2023, In: Nature Neuroscience. 39 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open Access -
Augmenting hematoma-scavenging capacity of innate immune cells by CDNF reduces brain injury and promotes functional recovery after intracerebral hemorrhage
Tseng, K-Y., Stratoulias, V., Hu, W-F., Wu, J-S., Wang, V., Chen, Y-H., Seelbach, A., Huttunen, H. J., Kulesskaya, N., Pang, C-Y., Chou, J-L., Lindahl, M., Saarma, M., Huang, L-C., Airavaara, M. & Liew, H-K., 15 Feb 2023, In: Cell Death and Disease. 14, 2, 20 p., 128.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Protective mechanisms by glial cell line-derived neurotrophic factor and cerebral dopamine neurotrophic factor against the ?-synuclein accumulation in Parkinson?s disease
Er, S. & Airavaara, M., 16 Feb 2023, In: Biochemical Society Transactions. 51, 1, p. 245-257 13 p.Research output: Contribution to journal › Review Article › peer-review
-
A novel variant in SMG9 causes intellectual disability, confirming a role for nonsense-mediated decay components in neurocognitive development
Rahikkala, E., Urpa, L., Ghimire, B., Topa, H., Kurki, M., Koskela, M., Airavaara, M., Hämäläinen, E., Pylkäs, K., Körkkö, J., Savolainen, H., Suoranta, A., Bertoli-Avella, A., Rolfs, A., Mattila, P., Daly, M., Palotie, A., Pietiläinen, O., Moilanen, J. & Kuismin, O., May 2022, In: European Journal of Human Genetics. 30, p. 619-627 9 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Cell Culture Media, Unlike the Presence of Insulin, Affect alpha-Synuclein Aggregation in Dopaminergic Neurons
Hlushchuk, I., Barut, J., Airavaara, M., Luk, K., Domanskyi, A. & Chmielarz, P., Apr 2022, In: Biomolecules. 12, 4, 15 p., 563.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile
-
BF R2B KAJO 23-24 Airavaara
Airavaara, M., Noutere, J. B. & STRATOULIAS, V.
Innovaatiorahoituskeskus Business Finland
01/01/2023 → 31/12/2024
Project: Business Finland
-
Yliopiston profilointi7 -InterEarth -ML
Airavaara, M., Heiskanen, J., Huiskonen, J., Hyvärinen, M., Kulmala, M., Kulmala, M., Mervaala, E., Primmer, C., Sironen, T., Toivonen, R., Auvinen, P., Eronen, J. T., Heikinheimo, A., Holopainen, M., Hyytiäinen, K., Karhu, K., Korpela, K., Lewandowska, A., Lindroos, M., Lintunen, A., Siven, M., Thomas, D. N., Tiira, T., Uimari, P., Vainio, A., Varjosalo, M. & Vartiainen, M.
Academy of Finland, Suomen Akatemia Projektilaskutus
01/01/2023 → 31/12/2028
Project: Academy of Finland: Strengthening university research profiles (PROFI)
-
Gliasolulinjaperäisen hermokasvutekijän merkitys alkoholihimossa
01/01/2014 → …
Project: Research project
-
Additional experiments with CDNF for the with 6-OHDA model Parkinson’s Research,
03/06/2013 → …
Project: Research project
-
Effects of Recombinant CDNF Protein in Alpha-synuclein Model of Parkinson’s Disease in Pre-Clinical Models
01/01/2013 → …
Project: Research project
Prizes
-
Innoopeli Prize 2022
Hanski, Leena (Recipient), Airavaara, Mikko (Recipient), Bunker, Alex Edwin (Recipient), Holmström, Anna-Riia (Recipient), Jeltsch, Michael (Recipient), Rantamäki, Tomi (Recipient), Sikanen, Tiina (Recipient), Voutilainen, Merja (Recipient), Lindstedt, Hanna Pauliina (Recipient), Kuusinen, Aarni (Recipient), Haapalainen, Joonatan Thomas Viljami (Recipient), Hintikka, Simo Johannes (Recipient), Baramaki, Iman (Recipient) & Kaukiainen, Kaisa (Recipient), 9 Dec 2022
Prize: Prizes and awards
Press/Media
-
Announcement: A study showing CDNF's therapeutic effects in alpha-synuclein-based animal models published
Henri Huttunen & Mikko Airavaara
20/05/2021
2 items of Media coverage
Press/Media: Press / Media
-
Herantis Pharma: Announcement: A study showing CDNF's therapeutic effects in alpha-synuclein-based animal models published
Henri Huttunen & Mikko Airavaara
20/05/2021
1 item of Media coverage
Press/Media: Press / Media
-
FinPharma kick-off webinar 21 October 2020
Tatu Lajunen, Michael Jeltsch, Tiina Sikanen, Mikko Airavaara & Jari Yli-Kauhaluoma
07/09/2020
1 item of Media coverage
Press/Media: Press / Media
-
Australia Patent: Helsingin Yliopisto Files Application for 'C-terminal CDNF and manf fragments, pharmaceutical compositions comprising same and uses thereof'
Maria Lindahl, Merja Voutilainen & Mikko Airavaara
01/12/2019
1 item of Media coverage
Press/Media: Press / Media
-
WIPO PUBLISHES PATENT OF HELSINGIN YLIOPISTO FOR "C-TERMINAL CDNF AND MANF FRAGMENTS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME AND USES THEREOF" (FINNISH INVENTORS)
Maria Lindahl, Merja Voutilainen & Mikko Airavaara
13/11/2018
1 item of Media coverage
Press/Media: Press / Media